Sinoatrial node (SA node)

The sinoatrial node is an elongated, oval-shaped cluster of specialized cardiac muscle cells (pacemaker cells) located in the upper posterior wall of the right atrium near the junction with the superior vena cava[1][7][8]. These cells possess the unique ability for self-excitation, producing spontaneous electrical impulses that initiate each heartbeat and propagate through the cardiac conduction system to synchronize atrial and ventricular contractions. The SA node's pacing rate is regulated by both sympathetic and parasympathetic nervous input, enabling heart rate modulation. The node's cellular composition is heterogeneous, with a gradient of electrophysiological properties and diverse molecular ion channel expression, vital for maintaining proper heart rhythm and adapting to physiological demands[4][6]. Dysfunction of the SA node results in rhythm disorders such as sick sinus syndrome and may lead to syncope, arrhythmias, or require implantation of artificial pacemakers[6][9]. Drugs and surgical interventions do not ‘target’ the node directly as a single molecule, but rather act on its function or constituent ion channels and regulatory mechanisms[6][5][2]. Note: The sinoatrial node as listed is a multicellular anatomical structure—not a molecule or receptor in the classical sense—so this entry does not map cleanly to most drug target databases or structures. For structured target information, the focus would move to individual ion channels or receptors (e.g., HCN4 channel, β-adrenergic receptor) that constitute the functional molecular machinery within the SA node[2][6].

Other names

Sinoatrial nodeSA nodesinus nodesinuatrial nodeKeith–Flack node

Inhibition of pacemaker ion currents (e.g., HCN/funny channels); Modulation of autonomic nervous input (sympathetic/parasympathetic); Alterations in Ca^2+^ or K^+^ channel activity; Direct or indirect effects on SAN cell excitability/action potential generation